JP2002540814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540814A5 JP2002540814A5 JP2000611075A JP2000611075A JP2002540814A5 JP 2002540814 A5 JP2002540814 A5 JP 2002540814A5 JP 2000611075 A JP2000611075 A JP 2000611075A JP 2000611075 A JP2000611075 A JP 2000611075A JP 2002540814 A5 JP2002540814 A5 JP 2002540814A5
- Authority
- JP
- Japan
- Prior art keywords
- flt
- molecule
- level
- tumor metastasis
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1999/008079 WO2000062063A1 (en) | 1999-04-13 | 1999-04-13 | Methods for the diagnosis and treatment of metastatic prostate tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540814A JP2002540814A (ja) | 2002-12-03 |
| JP2002540814A5 true JP2002540814A5 (enExample) | 2006-06-22 |
Family
ID=22272560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000611075A Pending JP2002540814A (ja) | 1999-04-13 | 1999-04-13 | 転移性前立腺腫瘍の診断および処置のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060234271A1 (enExample) |
| EP (1) | EP1175616A4 (enExample) |
| JP (1) | JP2002540814A (enExample) |
| AU (1) | AU775583B2 (enExample) |
| CA (1) | CA2370237A1 (enExample) |
| WO (1) | WO2000062063A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| US6692965B1 (en) * | 1999-11-23 | 2004-02-17 | Chromocell Corporation | Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences |
| US7611711B2 (en) | 2001-01-17 | 2009-11-03 | Vegenics Limited | VEGFR-3 inhibitor materials and methods |
| DE60235761D1 (de) | 2001-08-01 | 2010-05-06 | Univ Bristol Clifton | Isoform des vegfs |
| EP1448588A4 (en) | 2001-10-23 | 2006-10-25 | Psma Dev Company L L C | ANTIBODIES AND MULTIMERS OF PSMA PROTEINS |
| US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
| US8916503B2 (en) | 2004-02-18 | 2014-12-23 | Chromocell Corporation | Methods and materials using signaling probes |
| US7414254B2 (en) * | 2005-06-28 | 2008-08-19 | United Pharmacy Partners, Inc. | Tungsten pig for radio-pharmaceuticals |
| WO2007015935A2 (en) * | 2005-07-29 | 2007-02-08 | Bayer Healthcare Llc | Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| CA2646329C (en) | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| SG139563A1 (en) * | 2006-07-13 | 2008-02-29 | Shimadzu Corp | Diagnostic biomolecules |
| EP2079484A4 (en) * | 2006-09-07 | 2010-03-17 | Stemline Therapeutics Inc | MONITORING OF CANCER STEM CELLS |
| CA2698343C (en) | 2007-09-04 | 2018-06-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| CA2721169A1 (en) * | 2008-04-14 | 2009-10-22 | Proscan Rx Pharma Inc. | Prostate specific membrane antigen antibodies and antigen binding fragments |
| PL2326350T3 (pl) | 2008-09-08 | 2014-03-31 | Psma Dev Company L L C | Związki do zabijania eksprymujących PSMA, opornych na taksan komórek rakowych |
| US10517969B2 (en) | 2009-02-17 | 2019-12-31 | Cornell University | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| EP2506876B1 (en) | 2009-12-02 | 2016-10-12 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| JP6421118B2 (ja) * | 2012-10-02 | 2018-11-07 | メタノミクス ヘルス ゲーエムベーハー | 前立腺摘出術後の前立腺癌の再発の診断のための手段および方法 |
| CN108136012B (zh) | 2015-08-07 | 2022-10-04 | 伊麦吉纳博公司 | 靶向分子的抗原结合构建体 |
| US11266745B2 (en) | 2017-02-08 | 2022-03-08 | Imaginab, Inc. | Extension sequences for diabodies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635177A (en) * | 1992-01-22 | 1997-06-03 | Genentech, Inc. | Protein tyrosine kinase agonist antibodies |
| US5776755A (en) * | 1992-10-09 | 1998-07-07 | Helsinki University Licensing, Ltd. | FLT4, a receptor tyrosine kinase |
| US6824777B1 (en) * | 1992-10-09 | 2004-11-30 | Licentia Ltd. | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| JP3723210B2 (ja) * | 1994-06-09 | 2005-12-07 | ヘルシンキ ユニバシティ ライセンシング リミテッド オサケ ユキチュア | 受容体チロシンキナーゼであるｆｌｔ４ならびに診断および治療におけるその使用 |
-
1999
- 1999-04-13 AU AU36410/99A patent/AU775583B2/en not_active Ceased
- 1999-04-13 EP EP99918516A patent/EP1175616A4/en not_active Withdrawn
- 1999-04-13 WO PCT/US1999/008079 patent/WO2000062063A1/en not_active Ceased
- 1999-04-13 CA CA002370237A patent/CA2370237A1/en not_active Abandoned
- 1999-04-13 JP JP2000611075A patent/JP2002540814A/ja active Pending
-
2006
- 2006-04-27 US US11/380,592 patent/US20060234271A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002540814A5 (enExample) | ||
| JP2006500949A5 (enExample) | ||
| JP2009502115A5 (enExample) | ||
| Kubota et al. | Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line | |
| EP2890815B1 (en) | Methods for diagnosis and treatment of cancer | |
| US11591599B2 (en) | Method for the diagnosis, prognosis and treatment of cancer metastasis | |
| JP2006500948A5 (enExample) | ||
| JP2007506426A5 (enExample) | ||
| CA2318354A1 (en) | Biomarkers and targets for diagnosis, prognosis and management of prostate disease | |
| JP2012501164A5 (enExample) | ||
| JP2003508022A5 (enExample) | ||
| JP2008512984A5 (enExample) | ||
| JP2006518186A5 (enExample) | ||
| JP2011517937A (ja) | 体細胞性及び卵巣癌の診断のためのインビトロ診断方法 | |
| US20030232400A1 (en) | Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome | |
| KR100863405B1 (ko) | 암 진단 마커 및 이의 이용 | |
| KR100779752B1 (ko) | 호르몬으로 조절되는 종양에 적합한 안티센스 치료법 | |
| ATE466938T1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
| JP2006503575A5 (enExample) | ||
| Chen et al. | SLC6A15 acts as a tumor suppressor to inhibit migration and invasion in human papillary thyroid cancer | |
| JP2009505633A5 (enExample) | ||
| JP6508716B2 (ja) | 膀胱癌細胞のシスプラチン耐性マーカー及びその使用 | |
| Townshend et al. | An RNA aptamer that selectively inhibits the enzymatic activity of protein tyrosine phosphatase 1B in vitro | |
| KR20220139604A (ko) | 심혈관 질환과 관련된 LncRNA 및 이의 용도 | |
| JP2006501465A5 (enExample) |